The role of physical medicine and rehabilitation in haemophiliac patients
The coagulopathy of liver disease
Occurrence of thrombosis in congenital thrombocytopenic disorders
Diagnosis and treatment of intracranial hemorrhage in children with hemophilia
Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability
FcγRIIa and FcγRIIIa polymorphisms in childhood primary immune thrombocytopenia
African–Caribbean ethnicity is associated with a hypercoagulable state as measured by thrombin generation
High-density cholesterol and apolipoprotein AI as modifiers of plasma fibrin clot properties in apparently healthy individuals
Usefulness of mean platelet volume for predicting stroke risk in atrial fibrillation patients
Multiple markers of hypercoagulation in patients with history of venous thromboembolic disease
Prognostic value of computed tomographic pulmonary angiography and the pulmonary embolism severity index in patients with acute pulmonary embolism
The expression and concentration of CD40 ligand in normal pregnancy, preeclampsia, and hemolytic anemia, elevated liver enzymes and low platelet count (HELLP) syndrome
Comparison of empirical estimate of clinical pretest probability with the Wells score for diagnosis of deep vein thrombosis
Should low molecular weight heparin dosing be based on anti-Xa assays in antiphospholipid syndrome?
Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies
Takotsubo syndrome
Effectiveness of low-dose prolonged infusion of tissue plasminogen activator in a nonagenarian patient with acute pulmonary embolism and main pulmonary artery thrombus
Acquired factor V inhibitor developing in a patient with esophageal squamous cell carcinoma
Mucormycosis-associated intracranial hemorrhage
Successful use of recombinant factor VIIa in a child with Schoenlein–Henoch purpura presenting with compartment syndrome and severe factor XIII deficiency
Chronic circadian clock disruption induces expression of the cardiovascular risk factor plasminogen activator inhibitor-1 in mice